Brisson Drugs INC
Brisson Drugs INC was paid $39K by Medicaid between Oct 2019 and Sep 2022, across 10 billing codes. Its largest line is U0002, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc — 75% of everything it billed.
SAINT PAULS, NC 28384
Next to other Pharmacy providers in North Carolina
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 33 | $431.55 | |
| 2021 | 427 | $12K | |
| 2022 | 1,127 | $28K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 75% | 1,187 | 743 | $30K |
| 0011A | 8.6% | 69 | 68 | $3K | |
| 0012A | 7.9% | 49 | 49 | $3K | |
| 0001A | 4.5% | 36 | 36 | $2K | |
| 0002A | 2.8% | 18 | 18 | $1K | |
| 90688 | <1% | 16 | 16 | $232.05 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 17 | 17 | $199.50 |
| 91301 | 0% | 122 | 117 | $0.00 | |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 0% | 17 | 17 | $0.00 |
| 91300 | 0% | 56 | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Mary H Finch Total Care LLC | Broadway, NC | $1.38M |
| Hope Mills Pharmacy LLC | Hope Mills, NC | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.